Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Integra Medical

Latest From Integra Medical

Integra Adds ACell’s Regenerative Tech As It Dumps Extremity Orthopedics

Integra will pay up to $400m for ACell to expand its wound management and soft-tissue repair product line. The deal is part of a larger restructuring plan that includes selling its orthopedics business.

M & A Wound Healing & Tissue Repair

US FDA Announces Class I Recalls For Integra, Edwards Surgical Devices

The US Food and Drug Administration announced two class I recalls on 24 May. The recalls cover Integra’s LimiTorr Volume Limiting cerebrospinal fluid (CSF) drainage system and the MoniTorr intracranial pressure external CSF drainage and monitoring systems, as well as clinical platforms in Edwards’ EV1000 series.

United States FDA

Doors Close And Open For Oramed In China Diabetes Market

An intended licensing agreement between Wuzhou Zhongheng Group and Oramed for diabetes drugs may have fallen apart, but Zhongheng will continue to acquire new products abroad as part of its development strategy, while Oramed has tied up with another partner in the large and growing Chinese diabetes market, which has already attracted many multinationals.

BioPharmaceutical China

Orthopedic Implants: Interest Expands In Reverse Shoulders

With the economy improving and the total joint market slowly recovering, one of the brightest spots in the orthopedics industry is the market for shoulder replacements. While 2012 growth rates of total hips and knees are forecast in the low single digits – at 3% and 1%, respectively – the US shoulder replacement market is growing at a brisk 9.7% pace and is expected to reach approximately $620 million in revenues this year.

Medical Device
See All

Company Information

  • Industry
  • Services